Skip to content

Editorial Team

FDA Approves First Treatment for Advanced Dry AMD

Patients and doctors across the country are celebrating a monumental moment in the history of retinal care: the first treatment for advanced dry AMD (geographic atrophy) has been FDA-approved. Through monthly and bi-monthly pegcetacoplan injections, the studies demonstrated a meaningful reduction of lesion growth in patients with advanced dry AMD.

Thankful!

Ah, the holidays are, once again, upon us. This time of year, especially Thanksgiving, is a time for family visits and memory making, all while… Read More »Thankful!